Two-Year Clinical Study of Diffractive Multifocal Acri.Tec 366 IOL Implantation in 530 Eyes (original) (raw)

PURPOSE: To report on postoperative safety and efficacy outcomes with the diffractive Acri.Tec 366D implantation after cataract or clear lens surgery. METHODS: 530 eyes of 265 patients, 101 males and 164 females, age from 45.6 to 64.4 with diagnosis of cataract in 280 eyes, myopic clear lens in 14 eyes and hyperopic clear lens in 236 eyes. Diffractive Acritec 366D were implanted in all eyes from June 2006 to March 2008, and follow-up 6months in the shorter case. Safety, efficacy, predictability and complications were analyzed. RESULTS: The mean far visual acuity without correction was 0.81 monocular and 0.94 binocular; mean near vision without correction J3 monocular and J2.5 binocular; mean middle binocular vision J6.13. Intraoperative complications: zonular dialysis with vitreous in one eye, iris dehiscence in one eye. Postoperative complications: Macular cystoids thickness 1 eye, run out 1 eye and 78 capsular posterior fibrosis with yag capsulotomy were described. Global safety index 1.10 cataract group 1.15 and clear lens group 1.06. CONCLUSION: This study shows Difractive Multifocal Acri.Tec implantation to be a safety and effective method of refractive surgery in cataracts and myopic or hyperopic clear lens. However longer follow up is considered necessary.